טוען...
In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes
After the early advent of the Coronavirus Disease 2019 (COVID-19) pandemic, myriads of FDA-approved drugs have been massively repurposed for COVID-19 treatment based on molecular docking against selected protein targets that play fundamental roles in the replication cycle of the novel coronavirus. H...
שמור ב:
| הוצא לאור ב: | Environ Sci Pollut Res Int |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088405/ https://ncbi.nlm.nih.gov/pubmed/33934306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11356-021-14195-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|